125 related articles for article (PubMed ID: 12163398)
1. KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized?
Fletcher JA; Fletcher CD; Rubin BP; Ashman LK; Corless CL; Heinrich MC
Am J Pathol; 2002 Aug; 161(2):737-8; author reply 738-9. PubMed ID: 12163398
[No Abstract] [Full Text] [Related]
2. New activating mutation in GI stromal tumors.
Lang L
Gastroenterology; 2003 Mar; 124(3):596. PubMed ID: 12612892
[No Abstract] [Full Text] [Related]
3. Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis.
Willmore C; Holden JA; Zhou L; Tripp S; Wittwer CT; Layfield LJ
Am J Clin Pathol; 2004 Aug; 122(2):206-16. PubMed ID: 15323137
[TBL] [Abstract][Full Text] [Related]
4. Effects of loss-of-function and gain-of-function mutations of c-kit on the gastrointestinal tract.
Hirota S; Isozaki K; Nishida T; Kitamura Y
J Gastroenterol; 2000; 35 Suppl 12():75-9. PubMed ID: 10779223
[TBL] [Abstract][Full Text] [Related]
5. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.
Moskaluk CA; Tian Q; Marshall CR; Rumpel CA; Franquemont DW; Frierson HF
Oncogene; 1999 Mar; 18(10):1897-902. PubMed ID: 10086344
[TBL] [Abstract][Full Text] [Related]
6. [Gastrointestinal stromal tumors].
Schlemmer M; Milani V; Tschoep K; Fahn W; Wendtner CM
Dtsch Med Wochenschr; 2003 Sep; 128(39):2015-9. PubMed ID: 14508696
[No Abstract] [Full Text] [Related]
7. Apparent KIT Ser(715) deletion in GIST mRNA is not detectable in genomic DNA and represents a previously known splice variant of KIT transcript.
Lasota J; Kopczynski J; Majidi M; Miettinen M; Sarlomo-Rikala M
Am J Pathol; 2002 Aug; 161(2):739-41. PubMed ID: 12163399
[No Abstract] [Full Text] [Related]
8. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA
Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439
[TBL] [Abstract][Full Text] [Related]
9. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
[TBL] [Abstract][Full Text] [Related]
10. [Effect of c-kit gene mutation on prognosis of gastrointestinal stromal tumor].
Ma DL; Liu XH; Bai CG; Xie Q; Feng F
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):140-4. PubMed ID: 15062057
[TBL] [Abstract][Full Text] [Related]
11. c-kit Mutation in generalized lentigines associated with gastrointestinal stromal tumor.
Shibusawa Y; Tamura A; Mochiki E; Kamisaka K; Kimura H; Ishikawa O
Dermatology; 2004; 208(3):217-20. PubMed ID: 15118370
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features of gastric stromal tumors.
Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of c-kit gene mutations in gastrointestinal stromal tumors].
Hou YY; Sun MH; Tan YS; Wei YK; Lu XY; Zhang TM; Du X; Wang J; Zhu XZ
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):89-92. PubMed ID: 15059325
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile.
Allander SV; Nupponen NN; Ringnér M; Hostetter G; Maher GW; Goldberger N; Chen Y; Carpten J; Elkahloun AG; Meltzer PS
Cancer Res; 2001 Dec; 61(24):8624-8. PubMed ID: 11751374
[TBL] [Abstract][Full Text] [Related]
16. Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation.
Wakai T; Kanda T; Hirota S; Ohashi A; Shirai Y; Hatakeyama K
Br J Cancer; 2004 Jun; 90(11):2059-61. PubMed ID: 15150562
[TBL] [Abstract][Full Text] [Related]
17. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
Bernet L; Zuñiga A; Cano R
Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
[TBL] [Abstract][Full Text] [Related]
18. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.
Kinoshita K; Hirota S; Isozaki K; Ohashi A; Nishida T; Kitamura Y; Shinomura Y; Matsuzawa Y
J Pathol; 2004 Jan; 202(1):80-5. PubMed ID: 14694524
[TBL] [Abstract][Full Text] [Related]
19. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.
Chen LL; Trent JC; Wu EF; Fuller GN; Ramdas L; Zhang W; Raymond AK; Prieto VG; Oyedeji CO; Hunt KK; Pollock RE; Feig BW; Hayes KJ; Choi H; Macapinlac HA; Hittelman W; Velasco MA; Patel S; Burgess MA; Benjamin RS; Frazier ML
Cancer Res; 2004 Sep; 64(17):5913-9. PubMed ID: 15342366
[TBL] [Abstract][Full Text] [Related]
20. Assessing the prognosis of gastrointestinal stromal tumors: a growing role for molecular testing.
Corless CL
Am J Clin Pathol; 2004 Jul; 122(1):11-3. PubMed ID: 15272524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
